Daewoong Pharmaceutical And Hanall Biopharma Invest In Turn Biotechnologies To Expand Growth Initiative
Round Type
Funding Round
Description
Daewoong Pharmaceutical (KRX: 069620.KS) and HanAll Biopharma (KRX: 009420.KS) today announced expansion of their open collaboration strategy by investing in Turn Biotechnologies, a Silicon Valley based company focused on developing novel mRNA medicines. The companies are supporting Turn Bio's continued development of a high-potential platform and are considering future long-term collaborations.
Quick answer
Turn Biotechnologies raised an undisclosed amount in a Funding Round round, dated April 11, 2022.
- How much did Turn Biotechnologies raise?
- Turn Biotechnologies raised an undisclosed amount in a Funding Round round on April 11, 2022.
- What does Turn Biotechnologies do?
- Turn Bio is a pre-clinical-stage company focused on repairing tissue at the cellular level.
- Who are the decision-makers at Turn Biotechnologies?
- Fundz holds 1 contact at Turn Biotechnologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Turn Biotechnologies that raised within 45 days of this round, from Fundz verified event records.
- SpinaFX raised $6.9M (Series A) on May 26, 2022.
- Medical Informatics raised $15M on May 26, 2022.
- Aurora Cannabis raised $125M (Funding Round) on May 26, 2022.
- OliX Pharmaceuticals raised $45M (Funding Round) on May 25, 2022.
- Pleno raised $15M (Pre-Series A) on May 25, 2022.
- Castle Creek Biosciences, Inc raised $113M (Funding Round) on May 25, 2022.
Who to call at Turn Biotechnologies, and when
A new round usually means Turn Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Turn Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Turn Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Turn Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Turn Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Turn Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.